Contact
Please use this form to send email to PR contact of this press release:
AMAL Therapeutics Finalises €29 Million (CHF 33.2 Million) Series B Round
TO:
Please use this form to send email to PR contact of this press release:
AMAL Therapeutics Finalises €29 Million (CHF 33.2 Million) Series B Round
TO: